As of August 2024, Allergy Therapeutics has a market cap of $36.54M. This makes Allergy Therapeutics the world's 15823th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $21.18M | -4.00% |
2023 | $22.06M | -60.00% |
2022 | $55.16M | -80.62% |
2021 | $284.61M | 93.98% |
2020 | $146.72M | 62.20% |
2019 | $90.46M | -24.77% |
2018 | $120.24M | -52.19% |
2017 | $251.52M | 36.53% |
2016 | $184.23M | -29.24% |
2015 | $260.34M | 20.41% |
2014 | $216.22M | 206.25% |
2013 | $70.60M | -29.67% |
2012 | $100.39M | 10.98% |
2011 | $90.46M | 26.15% |
2010 | $71.70M | -44.92% |
2009 | $130.17M | 40.48% |
2008 | $92.66M | -73.08% |
2007 | $344.18M | -60.00% |
2006 | $860.46M | 26.62% |
2005 | $679.54M | -16.30% |
2004 | $811.92M | - |